Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells

Abstract

The promising antitumor effects of progesterone derivatives have been identified in many studies. However, the specific mechanism of action of this class of compounds has not been fully described. Therefore, in this study, we investigated the antiproliferative and (anti)estrogenic activities of novel pentacyclic derivatives and benzylidenes of the progesterone series. The antiproliferative effects of the compounds were evaluated on hormone-dependent MCF7 breast cancer cells using the MTT test. Estrogen receptor α (ERα) activity was assessed by a luciferase-based reporter assay. Immunoblotting was used to evaluate the expression of signaling proteins. All benzylidenes demonstrated inhibitory effects with IC 50 values below 10 µM, whereas pentacyclic derivatives were less active. These patterns may be associated with the lability of the geometry of benzylidene molecules, which contributes to an increase in the affinity of interaction with the receptor. The selected compounds showed significant anti-estrogenic potency. Benzylidene 1d ((8 S,9 S,10R,13 S,14 S,17 S)-17-[(2E)-3-(4-fluorophenyl)prop-2-enoyl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-3-one) was the most active in antiproliferative and anti-estrogenic assays. Apoptosis induced by compound 1d was accompanied by decreases in CDK4, ERα, and Cyclin D1 expression. Compounds 1d and 3d were characterized by high inhibitory potency against resistant breast cancer cells. Apoptosis induced by the leader compounds was confirmed by PARP cleavage and flow cytometry analysis. Compound 3d caused cell arrest in the G2/M phase. Further analysis of novel derivatives of the progesterone series is of great importance for medicinal chemistry, drug design, and oncology. Graphical Abstract Supplementary Information The online version contains supplementary material available at 10.1007/s10637-023-01332-z.

Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway

“…After a 24-h treatment with the indicated concentrations of doxazosin, the cells were incubated with MTT (final concentration 0.5 mg/ml) for 2 h. Then, the medium was removed and replaced with 100 µl DMSO to dissolve the formed purple formazan. An ELISA reader (570 nm) was used to assess the absorbance values ( 25 ).…”

Rapamycin inhibits B16 melanoma cell viability in vitro and in vivo by inducing autophagy and inhibiting the mTOR/p70‑S6k pathway

“…Membranes were then washed three times with PBS-0.05% Tween 20 and then incubated with HRP-coupled anti-rabbit or anti-mouse secondary antibodies (dilution of both, 1:10,000) for 2 h at room temperature. After PBS washing three times, protein bands were observed using a protein blotting assay kit (Applygen Technologies Inc.) with ultrasensitive enhanced chemiluminescence, and ImageJ software (National Institutes of Health) was used for semi-quantitative analysis of protein bands ( 27 ).…”

m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation

“…We added the MTT reagent to each well, then incubated the plate at 37 °C for 2 hrs, dissolved the precipitate in DMSO and measured the absorbance at 450 nm. Each sample was assayed in triplicate [26] .…”